David JacksonBiopharma Partnering and New Ventures Lead at Beth Israel Deaconess Medical CenterSpeaker
Agenda Sessions
Next Frontier Therapeutics: Reframing Modalities in RNA, Antibodies, and Beyond
, 10:50amView Session
